TradingKey sees MariTide, a GLP-1 and GIP antibody-peptide conjugate, as Amgen's biggest growth bet, with Q2 revenue at $10.1 billion and guidance raised.
Recap by typeshit. Full story at TradingKey.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Nearly 250 NAION cases sit in Pennsylvania federal court with hundreds more in New Jersey. Relkin, co-lead counsel, points to a baseline eye exam before starting a GLP-1.
A generic Facebook post aimed at people on Ozempic, Wegovy, Zepbound or Mounjaro, teasing an overlooked side of treatment without saying what it is.
Loading…